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ABSTRACT

combined oral and intraarticular ator-

Osteoarthritis (OA) is highly prev-

vastatine group. The drug given im-

alent chronic disease affecting syno-

mediately after surgical induction of

vial joints leading to irreversible dam-

OA for six weeks.. All atorvastatin

age to all joint structures. Statins, in

treated groups showed significant re-

addition to their cholesterol-lowering

duction in matrix metalloproteinase

activity, have pleiotropic effects. The

13 (MMP 13), interleukin- 1 ß (IL- 1

aim of this study is to evaluate and

ß) and tumor necrosis factor- α

compare the potential prophylactic

(TNF-α),

effects of oral, intraarticular atorvas-

and significant increase in reduced

tatin or their combination in surgical-

glutathione (GSH). Also, there were

ly induced OA in rats through medial

significant histological improvement

meniscal tear procedure. Rats were

compared to control osteoarthritic

divided into five groups; control nor-

non-treated group.

malondialdehyde

(MDA)

mal group, control non-treated osteoarthritic group, oral atorvastatine

It can be concluded that atorvas-

group (10 mg/kg), intraarticular ator-

tatin has beneficial prophylactic ef-

vastatine group (0.4mg/ /kg) and

fect and reduced the development of
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OA lesions in a rat model of OA

patients with substantial financial

when given early after surgical in-

consequences [3-4]. It has a multifac-

duction of OA either by oral, IA or

torial etiology, and can be consid-

combined routs and may be suggest-

ered the product of interactions be-

ed as a promising OA disease modi-

tween systemic and local factors in

fying drugs. It was also found that

the joint [5].

combined oral and IA administration
of atorvastatin produced better im-

Changes to any of the joint struc-

provement than oral or IA alone, this

tures can lead to an alteration in the

may be explained by synergism in

delicate balance between the joint

action of atorvastatin when given by

anabolic and catabolic processes,

combined oral and IA.

and consequently lead to perpetuating damage that may extend to all

Keywords: atorvastatine, Osteoarthritis, MMP13, IL1-β, MDA

joint structures [6]. Local inflammatory processes within the joint accompanied with dysregulated cytokine

INTRODUCTION

activities as interleukin- 1 ß (IL- 1 ß)

Osteoarthritis (OA) is a chronic,

and tumor necrosis factor- α (TNF-α)

painful and disabling condition affect-

shown to contribute to pathological

ing synovial joints characterized by

development of OA [7].

irreversible damage to all joint structures; articular cartilage, synovial

None of the available pharmaco-

membrane, and subchondral bone

logic therapies till this time was prov-

[1-2].

en to prevent or even retard the disease progression so end-stage in

OA

is

a

prevalent

disease;

OA disease may require joint re-

10–12% of the adult population has

placement [8]. However, advanced

symptomatic OA and further in-

researches and the progress made

crease has to be expected due to

in the understanding of the pathoph-

the increasing prevalence of obesity

ysiology of OA and the identification

and ascending life expectancy of

of risk factors have guided the devel-

population. OA leads to social, psy-

opment of OA disease modifying

chological and economic burdens in

drugs [9]. These drugs target to de-
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lay or even stop progression of joint

The purpose of this study was to

tissue damage and consequently de-

evaluate and compare oral and intra-

crease the need of joint replace-

articular atorvastatin and their combi-

ment.

nation in surgically induced OA in
rats.

3-hydroxy-3-methyl glutaryl coenzyme A reductase inhibitors (statins),
in

addition

lowering

to

their

activity,

cholesterol-

have pleiotropic

MATERIALS AND METHODS
2.1 Drugs
•

Atorvastatin as raw material

effects including antiinflammatory,

(white amorphous powder, soluble in

improvement of endothelial dysfunc-

water) from Egyptian International

tion, antioxidative properties, antipro-

Pharmaceutical Industry Company

liferative and antithrombotic effects

(EIPICO)

[10]. Atorvastatin was chosen as it is

relatively lipophilic; which can pas-

2.2 Animals

sively diffuse through different tis-

Fifty male Sprague-Dawley rats

sues including synovial membrane of

weighing 250-300 grams each were

the joint, has long half-life (20–30 h)

obtained from the medical experi-

[11] and the safety of high dose atorvastatin has been confirmed [12].

mental research center (Mansoura
faculty of medicine).

Rats

were

divided into five groups (n = 10/
Since oral administration of sta-

group) and housed under standard

tins could result in a relatively low

conditions for at least 1 week to

drug bioavailability to the joints, high

acclimate before starting the ex-

statin oral doses are required for

periments. They were put in similar

beneficial effects, this may increase

optimum

the risk of statin side effect, thus

free access to food and water. Ani-

alternative

mals were kept in cages at a room

routes of administration

housing

condition with

intra-

with controlled temperature 26 °C

articular (IA)) should be developed

and on a 12-h light–dark cycle. The

to

establish the entire therapeutic

local animal ethics committee has

potential of statins in clinical setting

approved in all experimental proce-

[13, 14].

dures.

of

the

drug

(transdermal,
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2.3 Induction of osteoarthritis

into four group of 10 rats in each, as

Surgical induction of OA was per-

a following:

formed on forty rats (four groups).

Group2: non-treated osteoarthritic

Animals were anesthetized by using

rats. They received oral normal sa-

mixture of diazepam (5mg/kg) and

line once daily from the first day of

ketamin (50mg/kg) intraperitoneal,

surgery for six weeks.

anesthesia

maintained

with

2%isoflurane inhalation.

Group 3: osteoarthritic rats were
treated

The right knee of the rats was

with

atorvastatin

solution

orally at a dose of 10mg /kg/ day and

shaved, sterilized by bitadine solu-

administrated by a gastric

tion, then the medial collateral liga-

from 1st day of surgery for six weeks

ment was exposed through a medial

[17].

gavage

midline skin incision, and was transected and the medial meniscus is

Group 4: osteoarthritic rats were

reflected medially toward the femur

treated with atorvastatin solution in-

and then cut. Skin incisions were

traarticularly at a dose of 0.4mg/ /kg

closed with5-0 Vicryl sutures, and

and injected intraarticularly by insulin

animals were allowed to recover

syringe once a week from 1st day of

from anesthesia [15,16].

surgery for six weeks [18]

2.4

Animal Grouping and Ex-

perimental Design
Group 1: SHAM rats that exposed

Group 5: osteoarthritic rats were
treated with combined oral atorvastatin 10mg /kg/ day and intraarticular

to the same surgical procedure but

atorvastatin

0.4mg/ /kg/ from 1st

without cutting the medial medial col-

day of surgery once a week for six

lateral ligament and the medial me-

weeks

niscus unoperated. They recieved
normal saline orally once daily for six
weeks.

At end of study rats were sacrificed using an over-dose of thiopental sodium (75 mg/kg body weight,

The forty rats with surgical induc-

i.p) [19]. Blood was withdrawn from

tion of osteoarthritis were divided

the heart of rats by 5 ml syringe.
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Blood samples were collected in a

reduced glutathione (GSH) in fresh

dry test tubes permitted to clump for

heparinized blood according to Beut-

30 minutes prior to centrifuge at

ler et al. [20] using (Bio-diagnostic

4000 revolutions per minute for 15

kit. Egypt)

minute and then serum was separat-

B. Colorimetric determination of

ed and collected in Eppendorf tube

serum lipid peroxide (Malondialde-

and kept frozen at -20°C till the time

hyde) according to Ohkawa et al. [21]

of measurement of MMP13, IL-1β,

using (Bio-diagnostic kit. Egypt)

TNF-α, MDA. Other amount of blood
(for measurement of GSH) was col-

2.6 Histopathological Examination

lected using heparin as an anticoag-

After extraction of the skin, oste-

ulant. Then the blood was diluted 4

otomy above and under the knee

times by distilled water to lyse the

joint and fixation of the specimens in

erythrocyte and the supernatate was

10% buffered formalin 24 h were

collected (erythrocyte lysate).

done [22]. The specimens then decalcified in 10% nitric acid for 5 days.

2.5 Biochemical Assay

Paraffin wax tissue blocks were pre-

1- Determination of serum MMP

pared for sectioning by sledge micro-

13 using rat MMP 13 ELISA Kit

tome at 4 µm thickness. The ob-

(Eiaab science com, Catalog No

tained tissue sections were collected

E0099r)

deparaffinized on glass slides. Histological examination of the slides

2- Determination of sera inflammatory markers:

stained by Haematoxyline and Eosin
(H/E), and semi quantitative histolog-

A. IL-1β concentration using rat

ical lesions grading (0-5) performed

IL-1β ELISA Kit (Boster biological

with scoring system in accordance to

technology, Catalog No. EK0393)

Khan et al. [23] as a follow:

B. TNF-α concentration using rat

0: Normal cartilage: Intact surface

TNF-α ELISA Kit (Rat TNF-α ELISA

layer, normal chondrocytes, nor-

Kit, RayBio.USA)

mal morphology of cells and continuous matrix.

4- Oxidative stress markers:
A. Colorimetric determination of

1: Rough surface: Irregular superficial layer (0.25), condensation of
MANSOURA MEDICAL JOURNAL
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superficial layer (0.25), prolifera-

groups, the significance of difference

tion of chondrocytes (0.25) and

was tested using ANOVA (analysis

initiation

of variance): Used to compare be-

of

cluster

formation

tween more than two groups of nu-

(0.25).
2: Surface discontinuity: All above

merical (parametric) data followed by

superficial

post-hoc tukey for multiple compari-

layer (1.20), cell death till mid

sons. A P value <0.05 was consid-

zone

ered statistically significant in all

and

discontinuous
(1.20),

hypercellularity

(1.20), disorientation of chondro-

analyses.

cyte columns (1.20) and cluster

RESULTS

formation (1.20).
3: Cleft formation:

All above and

large patches of cell death (2.25),

3.1

Effect

of

atorvastatin

on

MMP-13

sloughing of layers till mid zone

Surgical induction of OA in rats

(2.25), mild loss of matrix (2.25)

produced highly significant increase

and hypertrophy (2.25).

in serum MMP13 in control osteoar-

4: Erosion:

Sloughing of cellular

layers (3.20), maximum loss of
matrix (3.20), clusters of chon-

thritic group (group 2) compared to
control non-arthritic rats (group 1).
Oral, IA and combined (groups 3,

hypocellularity

4, 5 respectively) showed highly sig-

(3.20) and multiple patches of cell

nificant decrease in MMP-13 as com-

death (3.20).

pared with control OA group but still

drocytes

(3.20),

5: Denudation: Denudation of bone

significantly higher than control nor-

(4.25), maximum loss of cellular

mal group except group 5 which re-

layers and matrix (4.25), micro

ceive combined treatment where

fracture (4.25) and initiation of fi-

MMP-13 level not significantly differ

brosis (4.25).

from

control

non-arthritic

group.

There was no significant difference
2.7 Statistical analysis

between oral and IA treated groups

Data were analyzed using Statisti-

while combined group showed signif-

science

icant decrease in MMP13 compared

(SPSS) version 21. In the statistical

with either oral or IA prophylactic

comparison between the different

group.

cal

package

for

social
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3.2 Effect of atorvastatin on inflammatory markers

between oral and IA groups while
combined group showed significant

Surgical induction of OA in rats

increase in GSH and significant de-

produced significant increase in ser-

crease in MDA compared with either

um IL-1β, TNF-α in control osteoar-

oral or IA prophylactic group alone.

thritic group as compared with con-

Combined oral and IA atorvastatin

trol non-osteoarthritic rats Oral, IA or

treated group in both markers not

combined (groups 3, 4, 5 respective-

significantly differ from control non-

ly) produced highly significant de-

arthritic group (Table 3).

crease in IL-1β and TNF-α compared
with control OA group. Group 5,
which receive combined oral and IA

3.4 Effect of atorvastatin on histopathological score

atorvastatin, IL-1 β and TNF-α levels

As compared to histopathological

not significantly differed from control

examination of the normal non ar-

non-arthritic group. There was no

thritic rats (figure 1) which showed

significant difference between oral

intact histological picture; intact sur-

and IA treated groups while com-

face layer, normal chondrocytes or-

bined group showed significant de-

ientation, morphology of cells and

crease in IL-1β and TNF-α compared

continuous matrix (Grade 0), the his-

with either oral or IA treated group

topathological examination of the os-

alone (Table 2).

teoarthritic

rats

(figure

2A,

2B)

showed loss of superficial layer, cleft
3.3 Effect of atorvastatin on oxidative stress markers
Surgical induction of OA produced a significant decrease in GSH

formation, cell death, hypocellularity,
maximum loss of cellular layers and
matrix, erosion and matrix loss and
initiation of fibrosis (Grade 5)

and increase in MDA as compared to
normal group. Oral, IA, combined

The histopathological examina-

(groups 3, 4, 5 respectively) pro-

tion of the treated groups showed at-

duced significant increase in GSH

tenuation in the degree and severity

level and decrease in MDA com-

of pathological changes compared to

pared with control OA group, Also,

osteoarthritic non-treated group (fig-

there was no significant difference

ures 3, 4, 5 respectively).
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Surgical induction of OA in rats
produced highly significant increase
in histopathological score in control
osteoarthritic group (12.76±1.35)
(Table 4) as compared with that of
control non-osteoarthritic rats (group
1) (0±0). Oral, IA and combined
groups showed highly significant improvement in histological scores
(3.28±0.51, 2.95±0.44, 0.835±0.98)
compared with OA group but still sig-

nificantly higher than control normal
group except group 5, which receive
combined treatment, which show
non-significant difference from control non-arthritic group. Combined
group showed significant improvement compared with either oral
group alone or IA group alone while
there was no significant between
oral and IA groups
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Figure (1): Histopathological findings of hematoxylin and eosin-stained
normal articular cartilage section of proximal tibia: The articular cartilage shows (AC) smooth surface (arrow). The
chondrocytes appear normal in the matrix (arrow heads).
Normal bone marrow (BM) are seen.
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Figure (2 A): Histopathological findings of hematoxylin and eosin-stained osteoarthritic articular cartilage section: The cartilage from OA group
shows erosion in surface of the articular cartilage (arrow) with the
presence of underlying fibrous tissue (asterisk). Abnormal cavities
are seen in matrix (arrow heads) .

Figure (2 B): Histopathological findings of hematoxylin and eosin-stained osteoarthritic articular cartilage section: The cartilage from OA group
shows disrupted articular cartilage surface (arrow), area of ulceration (arrow head) and decrease number of chondrocytes (diamond)
and some cell death. There are subchondral bone cavities (asterisk).
MANSOURA MEDICAL JOURNAL

Published by Mansoura Medical Journal, 2023

11

Mansoura Medical Journal, Vol. 44 [2023], Iss. 1, Art. 8

156

POTENTIAL PROPHYLACTIC EFFECT OF ORAL etc...

Figure (3): Histopathological findings of hematoxylin and eosin-stained oral
atorvastatin treated group: The cartilage from oral group shows
less disrupted surface of articular cartilage, apperantly increase articular cartilage thickness with increased number of chondrocytes
(arrow head). Small cysts seen in subchondral bone (asterisk)

Figure (4): Histopathological findings of hematoxylin and eosin-stained

IA

treated group: The cartilage from IA group shows smooth surface of
articular cartilage (arrow), slight increase in articular cartilage
thickness with nearly normal number of chondrocytes .
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Figure (5): Histopathological findings of hematoxylin and eosin-stained of combined oral and IA group: The cartilage from combined group showing smooth surface of articular cartilage (arrow), nearly normal articular cartilage thickness with nearly normal number of
chondrocytes (arrow head).

DISCUSSION
According

gression or even reverse the disease

to American College

[25].

of Rheumatology, the pharmacologic
recommendations

for initial man-

agement of OA primarily

aims

to

alleviate symptoms, reduce pain and
control inflammation with paracetamol,

NSAIDs, opioid

intraarticular

analgesic or

corticosteroid injec-

tions [24].
Current drug development focuses on a new strategy in treatment of
OA to modify the progression of joint
structural changes and causes either
slowing the rate of disease progression, a complete stop of disease pro-

Surgically induced OA models
may be more clinically relevant than
chemically induced models because
the histopathological and biochemical changes that occur following surgical induction of OA are more similar to those seen in human OA [15].
In the present study, we evaluated the possible effect of statin in an
experimental model of osteoarthritis
as a potential OA disease modifying
drug. Atorvastatin was given as oral
(10mg/kg/day), IA (0.4mg/ /kg/week)
or by both oral and IA starting from
MANSOURA MEDICAL JOURNAL
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first day of surgical induction of OA
for successive 6 weeks.
The disease was evaluated by
histopathology and by chemical
markers that affect the pathogeneses of the joint structural changes
e.g pro-inflammatory cytokines (IL1β and TNFα), proteolytic enzymes
(MMP-13) and oxidative stress markers (MDA and GSH).
After induction of OA in rat, it was
found that there was significant increase of MMP-13 in osteoarthritic
group compared to normal nonarthritic group. The increase in level
of MMP-13 came in agreement with
other previous studies as Akasaki et
al, 2009 [26]. MMPs are the proteolytic enzymes increased in OA and
play a central role in the degradation
of articular cartilage. MMP-13 is the
key of these enzymes as it is the
most proficient at hydrolyzing bonds
in type II collagen, the most abundant type of collagen in articular cartilage [27, 28]. Atorvastatin treatment
in this study produced significant reduction of MMP-13in all atorvastatin
treated groups compared to nontreated arthritic group.
It was found also that there is sig-

nificant increase of IL-1 β and TNF α
in osteoarthritic group as compared
to normal non-arthritic group. The
progression of cartilage degradation
is
mediated
largely
by
proinflammatory cytokines mostly IL-1β
and TNFα. These cytokines contribute to tissue destruction by disrupting the balance of the catabolic and
anabolic activities of chondrocytes.
Much of the activities of these proinflammatory cytokines are mediated
by the activation of transcription factor NF?B. As a result, OA chondrocytes reduce expression of extracellular matrix components as type II
collagen and aggrecan as well as increased production of proteolytic enzymes as MMPs [29] Atorvastatin
produced significant reduction of IL-1
β and TNFα in all treated compared
to OA group
These anti-inflammatory effects of
statins appeared to be independent
of the cholesterol lowering activity.
Statin inhibit mevalonate synthesis
leading to a reduction in the synthesis of important intermediates, such
as the isoprenoids geranylgeranylpyrophosphate (GGPP) and farnesyl-pyrophosphate (FPP), These intermediates are involved in the posttranslational prenylation of several
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proteins (e.g., Ras, Rho, Rac) that
modify a variety of cellular processes
including cellular signaling, differentiation, proliferationcoagulation, oxidation, inflammatory and immunologic
responses [30]. Statins through its inhibition of these intermediate have
important pleiotropic effects; improvement of endothelial dysfunction, antioxidative properties, antiinflammatory, antiproliferative and
antithrombotic effects and neoangiogenesis so statins may be of potential therapeutic use in a variety of
non-vascular diseases, including autoimmune diseases, multiple sclerosis, arthritis, dementia and some
types of cancer [10]
Statins likely inhibit the expression of multiple inflammatory cytokines through its ability to inhibit nuclear factor kappa B (NF-κB)
activation that is transcriptional regulator of more than 40 inflammatory
genes. NF-κB is known to be activated via Rho GTPases and statin inhibit NF-κB through down-regulation
of Rho-related protein activation.
Statins also activate antiinflammatory transcription factors known as peroxisome proliferator–activated receptors, intracellular ligand-activated
transcription factors that interfere

159

with NF-κB transcriptional activity
[31].
The induction of OA was associated with increase in MDA, NO and
decrease in reduced glutathione as
compared to non-arthritic control
group in the current study.
Osteoarthritis is characterized by
increased markers of oxidative
stress; human articular chondrocyte
can actively produce reactive oxygen
species (ROS). ROS with oxidative
activity play an important role in the
chondrocyte catabolic program being
the mediators and effecters of cartilage damage [32] This negative effects through damage of membranes, modification of proteins and
DNA which disturb cartilage anabolism and promote catabolism and induce cell death [33].
Atorvastatin treatment produced
marked improvement of oxidative
stress markers, it decreases MDA
while GSH was increased in all treated groups
Statins reduce the production of
ROS by inhibiting the assembly and
activation of the nicotinamide adenine
dinucleotide
phosphate
MANSOURA MEDICAL JOURNAL
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(NADPH) complex. In addition, they
reduce oxidative stress by controlling
nitric oxide production and possibly
through their anti-inflammatory effects [34]. These effects of statin result from inhibition of mevalonate
pathway which results in a reduction
in the synthesis of important intermediates including isoprenoids [35].
Histological studies are more precise to detect the accurate severity
of OA. A simple and reproducible
histopathological score of experimentally induced OA in animals provide the necessary information about
structural changes in joints and their
degree of severity [23]. In the present
study, histopathological examination
and histological scoring were done
according to Khan et al, 2013 [23].
Development of OA in control arthritic rats was evident in histopathological examination as there were loss
of superficial layer, cleft formation,
cell death, hypocellularity, maximum
loss of cells and matrix, erosion and
matrix loss and fibrosis recording
score of 12.8 as compared the normal control saline treated non arthritic rats where histological picture is
completely normal; intact surface
layer, normal chondrocytes orientation, morphology of cells and contin-

uous matrix and allocated as zero
score. Groups treated with atorvastatin showed significant histological improvement than non- treated arthritic
group.
The combined oral and IA group
showed significant improvement than
either oral or IA alone. This can be
explained by synergistic effect of
combined oral and IA. The oral administration of statins result in a relatively low drug bioavailability to the
joints, and to reach with sufficient
amount high statin doses are required which increase the risk of statin-associated side effects [14]. Oral
administration of statin in usual dose
improve OA mainly through its systemic effect. It has been proposed
that the progression of OA to advanced states is driven by atheromatous vascular disease leading to subchondral bone ischaemia and
contributes to joint cartilage degeneration as a result of disturbance of its
nutritional supply [36]
Statins prevent atherosclerosis by
their lipid-lowering properties and antioxidant effects as they reduce susceptibility of LDL to oxidation and reduce the amount of oxidized Lowdensity lipoprotein (LDL) in plasma
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and within the atherosclerotic lesions
[37]. statins also modulate coagulation and exert antithrombotic effects
via a number of mechanisms including inhibition tissue factor synthesis
and increasing thrombomodulin formation via inhibition of geranylgeranylation of the Rho/Rho kinase pathway and, in turn nuclear factor-?B
activity, increasing endothelial nitric
oxide synthase activity, enhance fibrinolysis by its effect of protein C and
inhibit factor V and XIII activation
[38].
On the other hand, IA atorvastatin
improve OA mainly through its local
effect on the cartilage and subchondral bone more than in oral rout. Statin has direct anabolic effects on cartilage as it enhances aggrecan and
type II collagen gene expression and
proteoglycan synthesis. Such an effect appeared to be mediated by the
concomitant up-regulation of bone
morphogeneic potein-2, a key factor
in promoting chondrocyte differentiation and cartilage biosynthesis [39,
14]

Statins also interfere with osteoclast function with suppression of
bone resorption and have been
shown to promote osteoblast activity

161

through increased production of
bone morphogeneic protein-2, Such
effects should beneficially modify the
subchondral OA bone, already recognized as a potential target for
structure modification [40]

CONCLUSION
It can be concluded that Atorvastatin has beneficial effects and reduced the development of OA lesions in a rat model of OA when
given from the first day of surgical induction of OA either by oral, IA or
combined routs. Also, it was found
that combined oral and IA administration of atorvastatin produced better improvement than oral or IA
alone that may be explained by synergism in action of atorvastatin when
given by combined oral and IA.
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ا ﻠﺨــﺺ اﻟﻌﺮﺑــﻰ
ﺗﺄﺛﻴﺮ إﺳﺘﺨﺪام اﻷﺗﻮر ﻓﺎﺳﺘﺎﺗ ﻋﻦ ﻃﺮﻳﻖ اﻟﻔﻢ
ﻓﻰ ــﻮذج ﻳﺠﺮﻳﺒــﻰ ﳋﺸﻮﻧــﺔ ا ﻔﺎﺻــﻞ
ﻳـﻌـﺘـﺒـﺮ ﻣـﺮض ﺧـﺸـﻮﻧـﺔ اﻟـﻔـﺎﺻﻞ ﻣﻦ اﻻﻣـﺮاض ا ـﺰﻣـﻨـﺔ ﻛـﺜـﻴـﺮة اﻻﻧـﺘـﺸـﺎر .وﻳﺆﺛـﺮ ﻫـﺬا ا ـﺮض ﻋـﻠﻰ
ا ـﻔـﺎﺻﻞ اﻟـﺰﻻﻟـﻴـﻪ

ـﺎ ﻳـﺆدى إﻟﻰ أﺿـﺮار ﻻ رﺟـﻌـﺔ ﻓ ـﻴـﻬـﺎ ﳉـﻤـﻴﻊ اﺟـﺰاء ا ـﻔــﺼﻞ .ﺗـﺴـﺎﻋـﺪ اﻟـﻌﻼﺟـﺎت

اﳊـﺎﻟـﻴﺔ ﻟـﻌﻼج ﺧـﺸﻮﻧـﺔ ا ـﻔﺎﺻﻞ ﻏـﺎﻟـﺒـﺎ ﻋﻠﻰ ﺗـﻘـﻠﻴﻞ أﻋـﺮاض اﻷﻟﻢ واﻻﻟـﺘـﻬﺎب ﻣﻊ ﻋـﺪم اﻟـﺘﺄﺛـﻴـﺮ ﻋﻠﻰ
ﺗﻌﺪﻳﻞ وﻻ ﺗﺒﺎﻃﺆ ﺗﻘﺪم اﻟﺘﻐﻴﻴﺮات اﳊﺎدﺛﻪ ﺑﺎ ﻔﺼﻞ.
ﻳﻌﺪ اﻟﺴﺘـﺎﺗ

اﻟﺪواء اﻟﺬى ﻳﺴﺘﺨـﺪم ﻋﻠﻰ ﻧﻄﺎق واﺳﻊ ﻓﻰ ﻋﻼج اﺿﺮاﺑﺎت ﻣـﺴﺘﻮى اﻟﺪﻫﻮن ﺑﺎﻟﺪم

اﺣﺪ ﻫﺬه اﻻدوﻳﻪ اﶈﺘﻤﻠﻪ ﻟﻌﻼج اﳋﺸﻮﻧﻪ واﻳﻘﺎف آﺛﺎرﻫﺎ ا ﺪﻣﺮه ﻋﻠﻰ اﻧﺴﺠﺔ ا ﻔﺼﻞ
وﻗﺪ أﺟـﺮﻳﺖ ﻫﺬه اﻟﺪراﺳﺔ ﻟـﺘﻘﻴﻴﻢ وﻣـﻘﺎرﻧﺔ آﺛـﺎر اﻻﺗﻮرﻓﺎﺳﺘـﺎﺗ ا ﻤﻜـﻨﺔ ﻋﻦ ﻃﺮﻳﻖ اﻟﻔﻢ  ,اﳊﻘﻦ
داﺧﻞ ا ـﻔــﺎﺻﻞ أو ﺑـﺠ ـﻤـﻌـﻬـﻤــﺎ ﻣـﻌـﺎ ﻋـﻦ ﻃـﺮﻳﻖ اﻟـﻔﻢ وداﺧـﻞ ا ـﻔـﺎﺻﻞ ﻓﻲ ــﻮذج ﲡـﺮﻳـﺒـﻰ ﳋـﺸـﻮﻧـﺔ
ا ﻔﺎﺻﻞ ﻛﺪواء ﻣﺤﺘﻤﻞ ﻟﺘﻌﺪﻳﻞ ﻣﺮض ﺧﺸﻮﻧﺔ ا ﻔﺎﺻﻞ.
اﺟـﺮﻳﺖ ﻫـﺬه اﻟـﺪراﺳـﺔ ﻋـﻠﻰ ﻓﺌـﺮان ﺑـﻴـﻀـﺎء ﻣﻦ ﻓـﺼـﻴـﻠﺔ اﻟـﺴـﺒـﺮج دوﻟﻲ)ﻳـﺘـﺮاوح وزن اﻟـﻮاﺣﺪ -٢٥٠
٣٠٠ﺟﻢ( وﻗـﺴﻤﺖ اﻟﻰ ﺧـﻤﺲ ﻣـﺠﻤـﻮﻋـﺎت

) ١٠ﺑﻜﻞ ﻣـﺠـﻤﻮﻋـﺔ( ﻛﻤـﺎ ﻳـﻠﻰ :ﻣﺠـﻤـﻮﻋﺔ ﲢـﻜﻢ ﺳـﻠﻴـﻤﺔ,

ﻣﺠـﻤﻮﻋـﺔ ﲢﻜﻢ ﻣـﺮﻳﻀـﺔ ﻻﺗﺆﺧﺬ ﻋﻼج ,ﻣـﺠﻤﻮﻋـﺔ اﺟﺮي ﺑـﻬﺎ اﻟﻌـﻤﻠـﻴﺔ وﺗﺆﺧـﺬ اﻻﺗﻮرﻓـﺎﺳﺘﺎﺗـ ﺑﺎﻟﻔﻢ
ﺑﺠـﺮﻋﻪ  ١٠ﻣﺠﻢ/ﻛﺠﻢ ,ﻣـﺠﻤـﻮﻋﺔ اﺟﺮى ﺑـﻬﺎ اﻟﻌـﻤﻠـﻴﺔ وﺗﺆﺧـﺬ اﻻﺗﻮرﻓـﺎﺳﺘﺎﺗـ ﺑﺎﳊـﻘﻦ داﺧﻞ ا ﻔﺼﻞ
ﺑﺠﺮﻋـﺔ  ٠٫٤ﻣﺠﻢ/ﻛﺠﻢ ,ﻣﺠـﻤﻮﻋﺔ اﺟـﺮى ﺑﻬﺎ اﻟـﻌﻤﻠـﻴﺔ وﺗﺆﺧـﺬ اﻻﺗﻮرﻓﺎﺳـﺘﺎﺗ ﺑـﺎﻟﻔﻢ واﳊﻘﻦ داﺧﻞ
ا ـﻔـﺼﻞ ﻣﻌـﺎ ﺑـﻨﻔﺲ اﳉـﺮﻋـﺎت .و ﻗﺪ ﺧـﻀـﻌﺖ ﺟﻤـﻴـﻌﻬـﺎ ﻣـﺎﻋﺪا اﺠﻤﻟـﻤـﻮﻋﺔ اﻟـﺴـﻠﻴـﻤﻪ ﻻﺣـﺪاث ﺧﺸـﻮﻧﺔ
ـﻔﺼـﻞ اﻟﺮﻛـﺒﻪ اﻻ ﻦ ﺟـﺮاﺣـﻴـﺎ ﺑﻘـﻄﻊ اﻟـﺮﺑـﺎط اﳉـﺎﻧﺒـﻰ وﻗﻄﻊ ﺟـﺰء ﻣﻦ اﻟـﻐـﻀـﺮوف اﻻﻧﺴﻰ  ,ﺣﺪث
ﺗﺪﻫﻮر اﻟﻐﻀﺎرﻳﻒ ﺑﻌﺪ  ٣أﺳﺎﺑﻴﻊ ﺑﻌﺪ اﻟﻌﻤﻠﻴﻪ.
ذﺑﺢ اﻟـﻔـﺌﺮان ﺑـﻌـﺪ اﻧـﺘﻬـﺎء ﻣـﺪة اﻟـﺪراﺳﻪ و ﺗﻘـﻴﻢ ﺗـﺄﺛـﻴﺮ اﻻﺗـﻮرﻓـﺎﺳـﺘﺎﺗـ اﶈـﺘـﻤﻞ ﻋﻦ ﻃﺮﻳﻖ
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اﻟﻔﻢ ,ﺣﻘﻨﻪ داﺧﻞ ا ـﻔﺼﻞ وﺟﻤﻊ ﺗـﻨﺎوﻟﻪ ﻋﻦ ﻃﺮﻳﻖ اﻟﻔﻢ و اﳊـﻘﻦ داﺧﻞ ا ﻔﺼﻞ

168

أﺧﺬ ﻋـﻴﻨﺎت اﻟﺪم

ﻟ ـﻘـ ـﻴ ـ ــﺎس وﺳ ـﻄ ـ ـ ــﺎء اﻻﻟ ـﺘ ـﻬـ ـ ــﺎﺑـ ــﺎت  β- IL1)-و  (αTNF-اﻧــﺰ ﻣ ـ ـ ــﺬﻳﺐ  (13 - MMPووﺳــﺎﺋـ ــﻂ
اﻻﻛـﺴـﺪة )  MDAو  (GSH.وﺑـﺎﻹﺿـﺎﻓـﺔ إﻟـﻰ ذﻟﻚ
اﻹﺣـﺼﺎﺋﻰ ﺣـﻴﺚ

إﺟـﺮاء ﻓـﺤﺺ اﻷﻧـﺴـﺠــﺔ.

إﺟـﺮاء اﻟـﺘـﺤـﻠـﻴﻞ

ﺣـﺴﺎب ا ـﻘﺎرﻧـﺔ ﺑـ ﻣﺠـﻤـﻮﻋﻪ اﻟﺘـﺤﻜـﻢ اﻟﺘﻲ ﺗـﻌﺎﻧـﻲ ﻣﻦ اﳋﺸـﻮﻧﻪ ﻣﻊ ﻣـﺠﻤـﻮﻋﺔ

اﻟ ـﺘ ـﺤ ــﻜﻢ اﻟ ـﺴ ـﻠـ ـﻴــﻤﻪ اﻟــﺘﻲ ﻻﺗـ ـﻌــﺎﻧﻲ ﻣﻦ ﺧ ـﺸ ــﻮﻧــﺔ ا ـﻔــﺎﺻـﻞ واﺑ ـ اﺠﻤﻟ ـﻤــﻮﻋــﺎت اﻟ ــﺘﻰ

ﻋﻼﺟ ـﻬــﺎ

ﺑـﺎﻻﺗـﻮرﻓـﺎﺳـﺘـﺎﺗ ـ  .وﻗـﺪ أﻇـﻬـﺮت اﻟـﻨـﺘـﺎﺋﺞ ان اﻷﺗـﻮرﻓـﺎﺳـﺘـﺎﺗـ ﻟـﻪ ﺗـﺄﺛـﻴـﺮات ﻣـﻔـﻴـﺪة وﻳـﻘـﻠﻞ ﻣﻦ ﺗـﻄـﻮر
اﳋ ـﺸـﻮﻧﻪ ﻓﻰ ـﻮذج اﳋ ـﺸـﻮﻧﻪ ﺳـﻮاءا ﻋﻦ ﻃــﺮﻳﻖ اﻟـﻔﻢ اﳊـﻘﻦ داﺧﻞ ا ـﻔـﺼﻞ أو ﺟـﻤﻊ اﻟ ـﻄـﺮﻳـﻘـﺘـ
ﻣﻌـﺎ.ﻛﻤـﺎ وﺟﺪ ان ﺗـﻨﺎول أﻻﺗـﻮرﻓﺎﺳـﺘﺎﺗـ ﻋﻦ ﻃﺮﻳـﻖ اﻟﻔﻢ و اﳊـﻘﻦ داﺧﻞ ا ﻔـﺼﻞ ﻣﻌـﺎ أﻧﺘـﺠﺖ ﲢﺴـﻨﺎ
أﻓﻀﻞ ﻣﻦ اﺳﺘﺨﺪاﻣﻪ ﺑﺎﻟﻔﻢ ﻓﻘﻂ أو اﳊﻘﻦ داﺧﻞ ا ﻔﺼﻞ ﻓﻘﻂ.

Vol. 44, No. 1 & 2 Jan. & April, 2015

24

https://mmj.mans.edu.eg/home/vol44/iss1/8
DOI: 10.21608/mjmu.2015.124271

